The Business Development Office provides access to Queen Mary University of London cutting-edge capabilities and state-of–the-art facilities. Our team of Business Development Managers will identify relevant academic expertise to meet your commercial requirements through collaborative research, contract research and consultancy.
Quotient Sciences are dedicated to accelerating the development of new drugs for patients around the world. They provide formulation development, clinical pharmacology trials, and clinical and commercial manufacturing services to the pharmaceutical and biotech industry. These services are provided either individually or as an integrated service offering via their Translational Pharmaceutics® platform.. . For more than 30 years, Quotient Sciences has brought innovation to early drug development programs for pharmaceutical companies worldwide. At the company’s purpose built facilities, real-time manufacturing of all types of dosage forms is co-located with its clinical pharmacology unit to maximise flexibility, speed and cost savings for clients.
No data available
Established about 10 years ago to discover new anti-infection molecules to replace antibiotics and avoid resistance. We succeeded in creating a platform technology that offers several small molecules offering elimination of a range of pathogens to fight bacteria. viruses and fungal pathogens. It also offers performance in anti-aging, mental problems and solving many problems relating to the Gut Microbiome yet doing no damage to commensal bacteria or human cells. Our patent has been granted by EUIPO. Delivery systems have also been developed to work on other organs.
Reading Scientific Services Limited (RSSL) provides analytical, investigational, consultancy and training services to clients in the global biopharmaceutical, pharmaceutical and healthcare industries. We help our partners to develop drug products that are safe, innovative and of the highest quality.
Our GMP compliant facilities are located in the UK and with our team of more than 200 dedicated scientists, we ensure that every project is performed with our absolute commitment to outstanding quality, scientific excellence and customer satisfaction.
We offer a large portfolio of biological, microbiological, chemical and physical services to ensure the identity, purity, safety and quality of your biopharmaceutical through the full drug product life cycle.
Our comprehensive range of services include:
• Raw materials testing
• Biopharmaceutical characterisation
• Safety testing
• ICH stability testing
• Release testing
• Troubleshooting and contaminant identification
• 24/7 Emergency response service
• Training and consultancy
Our GMP compliant facilities are located in the UK and with our team of more than 200 dedicated scientists, we ensure that every project is performed with our absolute commitment to outstanding quality, scientific excellence and customer satisfaction.
We offer a large portfolio of biological, microbiological, chemical and physical services to ensure the identity, purity, safety and quality of your biopharmaceutical through the full drug product life cycle.
Our comprehensive range of services include:
• Raw materials testing
• Biopharmaceutical characterisation
• Safety testing
• ICH stability testing
• Release testing
• Troubleshooting and contaminant identification
• 24/7 Emergency response service
• Training and consultancy
With a client base representing companies from the FT Global 500 and FTSE listed companies, Reddie & Grose is recognised as a leading patent and trade mark firm. In 2009, the Managing Intellectual Property global patent survey ranked the firm as one of the UK’s top patent prosecution advisors. It consistently continues to achieve high rankings in all professional surveys.. . Reddie & Grose prides itself on delivering intellectual property protection for businesses in both the domestic and international marketplaces with a strong professional team of over 30 people from varied scientific backgrounds.. . The firm’s Cambridge office offers particular expertise in biotechnology, pharmaceutical, chemical, engineering, cleantech, instrumentation, medical device, materials, and software related inventions. Companies/academic institutions represented in this field by Reddie & Grose include: Diagnostics for the Real World, Haemostatix, Funxional Therapeutics, TCP Innovations, Trillion Genomics, Brax, Cambridge Biopolymers, Metalysis, University of Cambridge, Cambridge Broadband, i2, Cambridge Biotechnology Ltd and nCipher.. . Talk to us...
Watch our webinar with One Nucleus 'What are the IP Challenges at the Intersection of Life Sciences, Technology and Engineering Disciplines?' https://youtu.be/OHM3IoLoJ0Q
Watch our webinar with One Nucleus 'What are the IP Challenges at the Intersection of Life Sciences, Technology and Engineering Disciplines?' https://youtu.be/OHM3IoLoJ0Q
Restore Harrow Green is a specialist in laboratory logistics and delivers a wide range of expert services including project management, ground transportation, packing and casing, handling confidential laboratory data, cleanroom relocation and the transfer of hazardous material.
Our highly skilled and trained teams have the expertise required to handle every aspect of a laboratory relocation from chemicals, research samples and sensitive data to refrigerated components, instruments, tools and precision equipment. Whether you’re moving a single instrument, a priceless sample or planning a complex large scale relocation in the UK or overseas, our track record, skills and regulatory adherence makes us the first choice trusted partner in laboratory logistics.
We have insight and knowledge which has grown through a deep understanding of our Life Sciences and Healthcare customers and over 35 years of supporting organisations in the planning, implementation and delivery of laboratory relocations and instrument transportation.
Our highly skilled and trained teams have the expertise required to handle every aspect of a laboratory relocation from chemicals, research samples and sensitive data to refrigerated components, instruments, tools and precision equipment. Whether you’re moving a single instrument, a priceless sample or planning a complex large scale relocation in the UK or overseas, our track record, skills and regulatory adherence makes us the first choice trusted partner in laboratory logistics.
We have insight and knowledge which has grown through a deep understanding of our Life Sciences and Healthcare customers and over 35 years of supporting organisations in the planning, implementation and delivery of laboratory relocations and instrument transportation.
Horizon Discovery Group plc, a UK headquartered global life science company, is a world leader in gene editing and gene modulation. Through the application of these technologies the Company enables researchers to alter almost any gene or modulate its function in human or mammalian cells to generate models that mimic the genetic abnormalities found in diseases such as cancer. Horizon offers a catalogue of over 1,000,000 cell and reagent products, which along with related research services, support a greater understanding of the function of genes across all species and the genetic drivers of disease, and the development of personalised molecular, cell and gene therapies. These have been adopted by over 10,000 academic, drug discovery, drug manufacturing and clinical diagnostics customers around the globe, and are used in the Company’s own R&D pipeline.. . Horizon is headquartered in Cambridge, UK, and is listed on the London Stock Exchange’s AIM market under the ticker “HZD”. https://www.horizondiscovery.com . . •
No data available
Ride Therapeutics is a recently formed transatlantic biotechnology company with the mission of unlocking the full potential of mRNA & gene editing therapeutics through targeted & tunable delivery of these modalities. Founded by world-leading scientists from Harvard University & the University of Cambridge, Ride’s unique technology platform provides an entirely new approach to solving the delivery challenge at the molecular level. Powered by micro- and nano-engineering coupled to advanced data science, Ride is building the capability to deliver any molecular cargo, to any cell type, with a tunable release profile.